Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Kulicke & Soffa Industries Inc.

Start price
Target price
Perf. (%)
€42.29
06.01.23
€54.00
06.01.24
13.27%
25.05.23

Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
buy
BE Semiconductor Industries N.V.

Start price
Target price
Perf. (%)
€60.34
06.01.23
€70.00
06.01.24
3.81%
07.01.23

Could be worthwhile Investment >10% per year
buy
Siltronic AG

Start price
Target price
Perf. (%)
€70.40
06.01.23
€90.00
06.01.24
2.56%
07.01.23

Innovative
Market Leader or Top 3
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
AT&S Austria Technologie & Systemtechnik AG

Start price
Target price
Perf. (%)
€33.70
06.01.23
€40.00
06.01.24
0.30%
07.01.23

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.65
05.01.23
€25.00
05.02.23
23.66%
06.02.23

Could be very worthwhile Investment >20% year
buy
Fortinet Inc.

Start price
Target price
Perf. (%)
€45.58
05.01.23
€60.00
05.01.24
42.38%
20.05.23

Could be very worthwhile Investment >20% year
Fair valuation
Revenue growth >5% per year expected
Some uniques
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€1.73
05.01.23
€3.00
31.12.25
37.80%
06.01.23

Could be very worthwhile Investment >20% year
buy
Hugo Boss AG NA

Start price
Target price
Perf. (%)
€57.84
05.01.23
-
05.01.24
10.10%
06.01.24

buy
Silvergate Capital Corp.

Start price
Target price
Perf. (%)
€12.30
05.01.23
-
05.01.24
-6.50%
08.01.23

Risky Investment
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€50.74
05.01.23
€85.00
05.01.24
44.46%
12.06.23

Vyant Bio Inc.

Start price
Target price
Perf. (%)
€1.55
05.01.23
-
05.01.24
-65.81%
02.04.23

buy
Addex Therapeutics Sa

Start price
Target price
Perf. (%)
€0.67
05.01.23
€1.30
31.12.25
89.55%
06.02.23

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.20
04.01.23
-
04.01.24
-60.00%
20.01.23

Could be worthwhile Investment >10% per year
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€3.68
04.01.23
€5.00
31.12.25
25.54%
09.01.23

Could be very worthwhile Investment >20% year
buy
Aileron Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.16
04.01.23
€0.80
31.12.25
0.00%
06.02.23

Could be very worthwhile Investment >20% year
buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€81.82
04.01.23
€100.00
04.01.24
6.67%
20.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
04.01.23
-
04.01.24
-33.71%
22.01.23

Geron Corp.

Start price
Target price
Perf. (%)
€2.80
04.01.23
-
04.01.24
-29.37%
02.04.23

Probably not worthwhile Investment
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.50
04.01.23
€6.00
31.12.25
38.38%
04.01.23

Could be very worthwhile Investment >20% year
buy
Cancom SE

Start price
Target price
Perf. (%)
€28.94
04.01.23
€35.00
04.01.24
3.80%
07.01.23

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.27
03.01.23
-
03.01.24
-5.60%
08.01.23

Could be worthwhile Investment >10% per year
Meta Material Inc.

Start price
Target price
Perf. (%)
€1.04
03.01.23
-
03.02.23
-6.57%
24.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Bolt Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.30
03.01.23
€9.00
31.12.25
3.69%
05.05.23

Could be very worthwhile Investment >20% year
Uniper SE

Start price
Target price
Perf. (%)
€3.19
03.01.23
€1.00
03.01.24
-5.71%
23.01.23

Revenue decline/stagnation expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
overvalued